NaCl is one of 124 small molecule programs targeting Fatigue. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
121 competitors in Kidney Transplant
Ultomiris
Prevymis
NaCl
Biological/vaccine
Envarsus XR
Cytogam
Zemplar
Radicava
Cysteine Hydrochloride
Sensipar
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources